Perioperative management of anticoagulant therapy during cutaneous surgery: 2005 Survey of Mohs surgeons

Dermatologic Surgery

Volumn 33, Issue 10, 2007, Pages 1189-1197

  Kirkorian, A Yasmine ^a   Moore, Betty L ^a   Siskind, Jodi ^a   Marmur, Ellen S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CHEMOSURGERY; DEEP VEIN THROMBOSIS; DRUG WITHDRAWAL; EXCISION; EYELID RECONSTRUCTION; HEART INFARCTION; HUMAN; LIPOSUCTION; LUNG EMBOLISM; MEDICAL PRACTICE; PERIOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN BIOPSY; SKIN SURGERY; STROKE; SURGEON; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; DERMATOLOGY; DRUG UTILIZATION REVIEW; HUMANS; MOHS SURGERY; PERIOPERATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; SKIN DISEASES; TICLOPIDINE; UNITED STATES; VITAMIN E; WARFARIN;

EID: 34848891854     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33253.x     Document Type: Article

References (35)

1. Alcalay J, Alkalay R. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue? Dermatol Surg 2004 30 : 1091 4.
2. Syed S, Adams BB, Liao W, et al. A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery. J Am Acad Dermatol 2004 51 : 955 7.
3. Shalom A, Wong L. Outcome of aspirin use during excision of cutaneous lesions. Ann Plast Surg 2003 50 : 296 8.
4. Ah-Weng A, Natarajan S, Velangi S, Langtry JA. Preoperative monitoring of warfarin in cutaneous surgery. Br J Dermatol 2003 149 : 386 9.
5. Stables G, Lawrence CM. Management of patients taking anticoagulant, aspirin, non-steroidal anti-inflammatory and other anti-platelet drugs undergoing dermatological surgery. Clin Exp Dermatol 2002 27 : 432 5.
6. Kargi E, Babuccu O, Hosnuter M, et al. Complications of minor cutaneous surgery in patients under anticoagulant treatment. Aesthetic Plast Surg 2002 26 : 483 5.
7. Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg 2001 27 : 756 8.
8. Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg 1999 52 : 214 6.
9. West SW, Otley CC, Nguyen TH, et al. Cutaneous surgeons cannot predict blood-thinner status by intraoperative visual inspection. Plast Reconstr Surg 2002 110 : 98 103.
10. Douketis JD, Crowther MA, Cherian SS, Kearon CB. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1999 116 : 1240 6.
11. Currie CJ, Jones M, Goodfellow J, et al. Evaluation of survival and ischaemic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 2006 92 : 196 200.
12. Kimyai-Asadi A, Jih MH, Goldberg LH. Perioperative primary stroke: is aspirin cessation to blame? Dermatol Surg 2004 30 : 1526 9.
13. Collet JP, Himbert D, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2000 76 : 257 8.
14. Hackam DG, Kopp A, Redelmeier DA. Prognostic implications of warfarin cessation after major trauma: a population-based cohort analysis. Circulation 2005 111 : 2250 6.
15. Fischer LM, Schlienger RG, Matter CM, et al. Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarction. Arch Intern Med 2004 164 : 2472 6.
16. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2002 163 : 901 8.
17. Alam M, Goldberg LH. Serious adverse vascular events associated with perioperative interruption of antiplatelet and anticoagulant therapy. Dermatol Surg 2002 28 : 992 8.
18. Schanbacher CF, Bennett RG. Postoperative stroke after stopping warfarin for cutaneous surgery. Dermatol Surg 2002 26 : 785 9.
19. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol 2003 48 : 233 7.
20. Ong-Tone L, Paluck EC, Hart-Mitchell RD. Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of Cataract and Refractive Surgery members: Survey. J Cataract Refract Surg 2005 31 : 991 6.
21. Custer PL, Trinkhaus KM. Hemorrhagic complications of oculoplastic surgery. Ophthal Plast Reconstr Surg 2002 18 : 409 15.
22. Malden N. Dental procedures can be undertaken without alteration of oral anticoagulant regimen. Evid Based Dent 2005 6 : 11.
23. Jeske AH, Suchko GD. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 2003 134 : 1492 7.
24. Makar GA, Ginsberg GG. Therapy insight: approaching endoscopy in anticoagulated patients. Nat Clin Pract Gastroenterol Hepatol 2006 3 : 43 52.
25. Muskett A, Barber WH, Lineaweaver WC. The plastic surgeon's guide to drugs affecting hemostasis. Ann Plast Surg 2005 54 : 570 6.
26. Kovich O, Otley CC. Perioperative management of anticoagulants and platelet inhibitors for cutaneous surgery: a survey of current practice. Dermatol Surg 2002 28 : 513 7.
27. Thiele JJ, Hsieu SN, Ekanayake-Mudiyanselage S. Vitamin E: critical review of its current use in cosmetic and clinical dermatology. Dermatol Surg 2005 31 : 805 13.
28. Collins SC, Dufresne RG. Dietary supplements in the setting of Mohs surgery. Dermatol Surg 2002 28 : 447 52.
29. Dinehart SM, Henry L. Dietary supplements: altered coagulation and effects on bruising. Dermatol Surg 2005 31 : 819 26.
30. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996 348 : 1329 39.
31. Ringleb PA, Bhatt DL, Hirsch AT, et al. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke 2004 35 : 528 32.
32. Bhatt DL, Marso SP, Hisrch AT, et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002 90 : 625 8.
33. Bezerra DC, Bogousslavsky J. Antiplatelets in stroke prevention: the MATCH trial. Cerebrovasc Dis 2005 20 : 109 18.
34. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004 364 : 1519 21.
35. Bhatt DL, Topol EJ. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial. Am Heart J 2004 148 : 263 8.